| E. COLI | Monitoring | 0 | N/A | Nov 14, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 14, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 14, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 11, 2024 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 11, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Oct 3, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Oct 3, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 11, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Sep 11, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | May 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 3, 2021 | Resolved | N/A |